2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Opioid Withdrawal: new trials by email Literature Review of Opioid Withdrawal trials Research Report on Opioid Withdrawal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Innovative Intervention for OUD Treatment Bridge Device, Lofexidine, Placebo - Opioid-Related Disorders, Opioid Dependence | Phase 2 / Phase 3 | Completed | Johns Hopkins University | 36 | 2020-11-15 | 2026-06-09 |
| Open-Label, Safety Study of Lofexidine Lofexidine - Opioid Withdrawal | Phase 3 | Completed | USWM, LLC (dba US WorldMeds) | 286 | 2015-02-01 | 2022-03-22 |
Chemically-Induced Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
lofexidine (2)
Johns Hopkins University (1) · USWM, LLC (dba US WorldMeds) (1)
United States (2)
Charles W Gorodetzky, MD, PhD (1) · Eric Strain (1)
R01DA048761 (1), U01DA033276 (1)